SCHEMBL20736918

SCHEMBL20736918

c1ccc(N(c2ccc3c4c(c5ccccc5c3c2)-c2c(cc(N(c3ccccc3)c3cccc5c3oc3ccccc35)c3ccccc23)C42c3ccccc3-c3ccccc32)c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20736083 0.95 ALOX5 (0.33) ALOX5
SCHEMBL20736156 0.95 ALOX5 (0.36) ALOX5
SCHEMBL20736081 0.95 ALOX5 (0.31) ALOX5
SCHEMBL20737544 0.94 ALOX5 (0.31) ALOX5
SCHEMBL27250102 0.93 ALOX5 (0.31) ALOX5
SCHEMBL27250104 0.92 ALOX5 (0.31) ALOX5
SCHEMBL20737543 0.91 ALOX5 (0.30) ALOX5
SCHEMBL20735626 0.91 — —
SCHEMBL20735807 0.91 ALOX5 (0.31) ALOX5
SCHEMBL20736923 0.91 AHR (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-20230009458-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-12 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20220416170-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed
US-20220416171-A1 ORGANIC ELECTROLUMINESCENT DEVICE CONFIGURED TO EMIT LIGHT WITH HIGH LUMINOUS EFFICIENCY IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed
US-20220310930-A1 ORGANIC ELECTROLUMINESCENT ELEMENT EMITTING LIGHT AT HIGH LUMINOUS EFFICIENCY AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-09-29 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 ALOX5 980/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 ALOX5 980/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 ALOX5 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback